title: CXCR2 inhibition in pancreatic cancer: opportunities for immunotherapy?
authors.affiliation: Cancer Research UK Beatson Institute, Switchback Rd, Glasgow, G61 1BD, UK.|Institute of Cancer Sciences, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.
authors.forename: Jennifer P
authors.initials: JP
authors.lastname: Morton
authors.affiliation: Cancer Research UK Beatson Institute, Switchback Rd, Glasgow, G61 1BD, UK.|Institute of Cancer Sciences, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.
authors.forename: Owen J
authors.initials: OJ
authors.lastname: Sansom
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D060890:B7-H1 Antigen / Q000276:immunology; D044584:Carcinoma, Ductal / Q000276:immunology / Q000628:therapy*; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007249:Inflammation / Q000276:immunology / Q000628:therapy*; D000072737:Myeloid-Derived Suppressor Cells / Q000276:immunology*; D010190:Pancreatic Neoplasms / Q000276:immunology / Q000628:therapy*; D023063:Receptors, Interleukin-8B / Q000037:antagonists & inhibitors*; D015398:Signal Transduction
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D060890:B7-H1 Antigen; D023063:Receptors, Interleukin-8B
keywords: CXCR2; anti-PD1; chemokines; immunotherapy; metastasis; pancreatic cancer